1. 1304PDCorrelation of radiation pneumonitis history before nivolumab and onset risk of interstitial lung disease or progression free survival of nivolumab in patients with non-small cell lung cancer. (18th September 2017) Authors: Tamiya, A.; Tamiya, M.; Nakahama, K.; Taniguchi, Y.; Shiroyama, T.; Isa, S-I.; Inoue, T.; Nishino, K.; Kumagai, T.; Suzuki, H.; Hirashima, T.; Imamura, F.; Atagi, S. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer. (September 2015) Authors: Tamiya, M.; Tamiya, A.; Kaneda, H.; Nakagawa, K.; Goto, K.; Yoh, K.; Okamoto, H.; Shimokawa, T.; Abe, T.; Tanaka, H.; Daga, H.; Takeda, K.; Atagi, S.; Hirashima, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3078 Updated results and efficacy analysis according to epidermal growth factor receptor (EGFR) mutation subtypes and metastatic sites for the phase II trial of gefitinib in combination with carboplatin plus S1. (September 2015) Authors: Tamiya, A.; Tamiya, M.; Shiroyama, T.; Tsuji, T.; Morishita, N.; Omachi, N.; Okamoto, N.; Hidekazu, S.; Okishio, K.; Hirashima, T.; Atagi, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. (September 2015) Authors: Tamiya, A.; Yoshioka, H.; Nishimura, T.; Iwamoto, Y.; Kim, Y.H.; Tomii, K.; Katakami, N.; Komuta, K.; Nishikawa, M.; Yamaki, K.; Gemma, A.; Kawahara, M.; Atagi, S.; Yamanaka, T.; Miyakoshi, C.; Mio, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC). (September 2015) Authors: Sakai, H.; Nishio, M.; Hida, T.; Nakagawa, K.; Nogami, N.; Atagi, S.; Takahashi, T.; Nokihara, H.; Saka, H.; Takenoyama, M.; Fujita, S.; Tanaka, H.; Takeda, K.; Satouchi, M.; Isobe, H.; Maemondo, M.; Goto, K.; Hirashima, T.; Minato, K.; Tamura, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗